Tag: Drug

Contrast Shortage Update: U.S. Providers Can Now Order Bayer Contrast Media with Foreign Labels, USA Granted Permission

The shortage of iodinated contrast media is no longer a less-known matter. The FDA (Food and Drug Administration), the USA has recently granted Bayer’s permission for importing Ultravist from other countries to dissipate the impact of the ongoing shortage. According to Bayer’s communications, Ultravist, intended for the USA market, and the contrast agent share a […]

Digitized and Data-driven, Drug Development is Posed for a Major Leap Forward

Drug development is all set to become considerably faster, sharper, and better in times to come. With a perfect innovative idea developing around the combination of Big Data, ingestible and wearable sensors, and monitors, with AI-augmented data analytics, there is hope. According to the authors of a piece published in the Harvard Business Review, on […]